Does Zydus’ Promising CAPS Candidate Have An Edge Over Novartis’ Ilaris?

Potential In Chronic Inflammatory Diseases

Rare Disease Sign
Pharma Has Increased Focus On Rare Diseases • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from R&D

More from Scrip